MY181172A - Composite preparation comprising active ingredient-containing film coating layer - Google Patents

Composite preparation comprising active ingredient-containing film coating layer

Info

Publication number
MY181172A
MY181172A MYPI2016002270A MYPI2016002270A MY181172A MY 181172 A MY181172 A MY 181172A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY 181172 A MY181172 A MY 181172A
Authority
MY
Malaysia
Prior art keywords
film coating
coating layer
composite preparation
active ingredient
containing film
Prior art date
Application number
MYPI2016002270A
Other languages
English (en)
Inventor
Hyung Seo Kim
Jung Hyun Cho
Jin Cheul Kim
Yong Ii Kim
Jae Hyun Park
Jong Soo Woo
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Priority claimed from KR1020150093777A external-priority patent/KR20160002411A/ko
Publication of MY181172A publication Critical patent/MY181172A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI2016002270A 2014-06-30 2015-06-30 Composite preparation comprising active ingredient-containing film coating layer MY181172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20140081223 2014-06-30
KR1020150093777A KR20160002411A (ko) 2014-06-30 2015-06-30 5-α-환원효소 억제제-함유 필름 코팅층을 포함하는 복합제제 및 그 제조방법

Publications (1)

Publication Number Publication Date
MY181172A true MY181172A (en) 2020-12-21

Family

ID=55019633

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016002270A MY181172A (en) 2014-06-30 2015-06-30 Composite preparation comprising active ingredient-containing film coating layer

Country Status (2)

Country Link
MY (1) MY181172A (fr)
WO (1) WO2016003180A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020023613A2 (pt) 2018-05-19 2021-02-17 Zim Laboratories Limited nova composição farmacêutica de tansulosina e dutasterida

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005016981A1 (de) * 2005-04-13 2006-10-19 Bayer Healthcare Ag Kombination zur Therapie bei benigner Prostatahyperplasie
EP2515882A2 (fr) * 2009-12-22 2012-10-31 Abbot Healthcare Private Limited Composition pharmaceutique à libération contrôlée
WO2012127495A2 (fr) * 2011-02-28 2012-09-27 Titan Laboratories Pvt. Ltd. Composition pharmaceutique et son procédé de préparation
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물
KR20140013436A (ko) * 2012-07-24 2014-02-05 한미약품 주식회사 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제

Also Published As

Publication number Publication date
WO2016003180A1 (fr) 2016-01-07

Similar Documents

Publication Publication Date Title
PH12016502536A1 (en) Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation
CL2017000288A1 (es) Encapsulación de compuestos hidrofóbicos biologicamente activos
MX2017008425A (es) Composiciones fungicidas.
CL2017003067A1 (es) Piridinas sustituidas y método de uso
ECSP18039913A (es) Sililfenoxiheterociclos trisustituidos y análogos
EP3369792A4 (fr) Film antisalissure, composition filmogène antisalissure, stratifié de film antisalissure et procédé de production d'un stratifié de film antisalissure
EP3206706A4 (fr) Composition injectable stable d'agents pharmaceutiquement actifs et procédé de préparation associé
CL2013002504A1 (es) Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion
EP3225685A4 (fr) Solution de conservation de cellules, son utilisation et procédé de production d'une solution de conservation de cellules
CO6660482A2 (es) N-[(het)]ariletil)pirazol](tio) carboximidas y sus análogos heterosustituidos
UY35047A (es) Procedimiento de preparación de un fertilizante de liberación lenta
AR102563A1 (es) Composición densificada para el tratamiento de una formación subterránea
EP3241875A4 (fr) Composition de résine pour revêtement dur, et film de revêtement dur comprenant une forme durcie de cette dernière en tant que couche de revêtement
EP3138834A4 (fr) Dérivé de cyclohexène, son procédé de préparation et composition pharmaceutique pour prévenir ou traiter des maladies métaboliques, contenant celui-ci comme principe actif
PH12016500865A1 (en) Composite formulation comprising tadalafil and amlodipine
MX2017006524A (es) Composicion adhesiva que cambia de color.
EP3315137A4 (fr) Composition pour couche externe de préparation solide, et préparation solide facile à prendre contenant cette composition pour couche externe
EP3281980A4 (fr) Composition de résine et structure multicouche l'utilisant, et procédé pour améliorer la stabilité à long terme
EP3124442A4 (fr) Procédé pour empêcher des larves au stade d'adhérence de nager ou de ramper
EP3205924A4 (fr) Cellule luminescente électrochimique et composition pour formation de couche luminescente de cellule luminescente électrochimique
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EP3241824A4 (fr) Composé d'hydrazide trifluoroacétique ainsi que son procédé de préparation et son application dans la préparation d'un médicament
EP3207945A4 (fr) Formulation de metformine à libération prolongée et procédé pour sa préparation
EP3257934A4 (fr) Nouvelle souche produisant un acide organique dibasique ainsi qu'application et préparation de celle-ci
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.